Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Heavy drinking can hasten the progression of the simian immunodeficiency virus disease

26.09.2006
Alcohol abuse can impair a person's immune system.
Alcohol abuse is also very common among individuals infected with human immunodeficiency virus (HIV).
New findings indicate that heavy drinking can accelerate time to AIDS among rhesus macaques infected with simian immunodeficiency virus (SIV).

Alcohol abuse can impair a person's immune system, leading to infections like pneumonia. Alcohol abuse is also more common among individuals already infected with human immunodeficiency virus (HIV) than among the population as a whole. New research findings show that chronic binge drinking can accelerate the progression of end-stage simian immunodeficiency virus (SIV) among rhesus macaques, likely mimicking what happens to humans infected with HIV.

Results are published in the October issue of Alcoholism: Clinical & Experimental Research.

"Previous research has found that HIV-infected people are more likely to consume alcohol than the general population," said Gregory J. Bagby, professor of physiology and medicine at Louisiana State University Health Sciences Center and corresponding author for the study. "One very recent study conducted in Miami, for example, found that more than 60 percent of its HIV-infected participants reported heavy alcohol use."

Bagby said that the protracted nature of HIV disease, along with the complex behaviors of HIV+ patients, makes the study of alcohol consumption or abuse on HIV-disease progression extremely difficult.

"While alcohol abuse is known to impair immune defenses," he said, "resulting in a higher incidence and severity of infections – especially pneumonia – the adverse consequences of heavy alcohol consumption on the HIV-infected patient as it relates to disease progression are poorly understood. The few studies that exist have failed to find an association between alcohol use and HIV disease progression. For this reason, we adopted the rhesus macaque SIV model of HIV disease in order to more effectively isolate the effect of alcohol consumption on infectivity, pathogenesis and progression."

"The key issue with alcohol consumption and HIV/AIDS is when to start individuals on life-saving antiretrovirals versus the need to avoid their toxic effects that damage the liver and gut along with the alcohol," added Kendall Bryant, coordinator of HIV/AIDS research at the National Institute on Alcohol Abuse and Alcoholism. "This 'set point,' which is unobserved, is not characterized by traditional measures of disease status. Dr. Bagby's research suggests that the speed of progression of AIDS – at least for alcohol users – is in part set by past and current drinking very early on in the disease. This tells us that we need to get HIV+ alcohol users into treatment much earlier in order to reduce their alcohol use."

For 12 weeks, study authors administered alcohol to 16 male rhesus macaques for five hours on four consecutive days per week via an indwelling intragastric catheter in order to attain a blood alcohol concentration of 0.23 to 0.28 percent. This would be considered the human equivalent of "chronic binge drinking." Control rhesus macaques (n=16 males) were given a sucrose solution under the same conditions. After three months, eight alcohol-treated and eight sucrose-treated macaques were inoculated with 10,000 times the ID50 of SIVDeltaB670 and followed to end-stage disease. Eight alcohol-treated and eight sucrose-treated macaques were not infected with SIV.

"There are two key findings," said Bagby. "First, chronic binge alcohol consumption accelerated time to AIDS of rhesus macaques infected with SIV, a virus that mimics what happens to humans infected with HIV. The average time to end-stage disease was decreased from 900 days in control animals to 374 days in the alcohol-treated rhesus monkeys. Second, animals receiving alcohol had higher viral loads in the blood in the early months after being infected with the virus. This higher viral load is associated with more rapid disease progression in both SIV-infected rhesus macaques and HIV-infected humans. Because SIV infection in rhesus macaques is so similar to what happens in HIV infected humans, we can expect that alcohol would have similar consequences in humans."

"The study gives us one more piece of the puzzle about the complex effects of alcohol on the progression of HIV disease," said Bryant. "What people don't realize is how complex the life cycle of the virus is and how it interacts in a very directed way with host characteristics such as drinking. We want to lengthen the life of HIV-infected individuals so that they can live a life as anyone with a chronic disease that needs to be managed. If these findings are confirmed in HIV+ individuals, the prevention implications are that both past and current alcohol use impacts disease progression and that many additional years of life will be lost if one continues to drink while infected."

Bagby noted that although his study implicates alcohol abuse as a cofactor in accelerating SIV disease progression and, by extrapolation, HIV disease – the exact mechanisms by which this occurs remain unclear.

"Each episode of alcohol intoxication can suppress multiple elements of immune function in humans," he said. "This suppression can be largely responsible for the increased incidence of infections such as pneumonia. However, chronic alcohol consumption can also stimulate the immune system, leading to diseases like hepatitis. In this case, perhaps both effects of alcohol are involved: immunosuppression could increase the incidence of opportunistic infections, and immune stimulation could activate cells infected with the virus, causing more cells to become infected."

Notwithstanding what mechanisms may be involved, both Bagby and Bryant said that HIV+ individuals must realize that heavy alcohol consumption can accelerate disease progression to AIDS and death.

"We also need to prioritize questions and realize that the HIV epidemic is still with us and that it is growing in many countries with few health resources," said Bryant. "Alcohol use is an important modifiable factor in the AIDS epidemic. It should not be overlooked or underfunded."

Kendall Bryant | EurekAlert!
Further information:
http://www.nih.gov

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>